OBJECTIVES: To predict the probability of malignancy for MRI-detected breast lesions with a multivariate model incorporating patient and lesion characteristics. METHODS: Retrospective review of 2565 breast MR examinations from 1/03-11/06. BI-RADS 3, 4 and 5 lesions initially detected on MRI for new cancer or high-risk screening were included and outcomes determined by imaging, biopsy or tumor registry linkage. Variables were indication for MRI, age, lesion size, BI-RADS lesion type and kinetics. Associations with malignancy were assessed using generalized estimating equations and lesion probabilities of malignancy were calculated. RESULTS: 855 lesions (155 malignant, 700 benign) were included. Strongest associations with malignancy were for kinetics (washout versus persistent; OR 4.2, 95% CI 2.5-7.1) and clinical indication (new cancer versus high-risk screening; OR 3.0, 95% CI 1.7-5.1). Also significant were age > = 50 years, size > = 10 mm and lesion-type mass. The most predictive model (AUC 0.70) incorporated indication, size and kinetics. The highest probability of malignancy (41.1%) was for lesions on MRI for new cancer, > = 10 mm with washout. The lowest (1.2%) was for lesions on high-risk screening, <10 mm with persistent kinetics. CONCLUSIONS: A multivariate model shows promise as a decision support tool in predicting malignancy for MRI-detected breast lesions.
OBJECTIVES: To predict the probability of malignancy for MRI-detected breast lesions with a multivariate model incorporating patient and lesion characteristics. METHODS: Retrospective review of 2565 breast MR examinations from 1/03-11/06. BI-RADS 3, 4 and 5 lesions initially detected on MRI for new cancer or high-risk screening were included and outcomes determined by imaging, biopsy or tumor registry linkage. Variables were indication for MRI, age, lesion size, BI-RADS lesion type and kinetics. Associations with malignancy were assessed using generalized estimating equations and lesion probabilities of malignancy were calculated. RESULTS: 855 lesions (155 malignant, 700 benign) were included. Strongest associations with malignancy were for kinetics (washout versus persistent; OR 4.2, 95% CI 2.5-7.1) and clinical indication (new cancer versus high-risk screening; OR 3.0, 95% CI 1.7-5.1). Also significant were age > = 50 years, size > = 10 mm and lesion-type mass. The most predictive model (AUC 0.70) incorporated indication, size and kinetics. The highest probability of malignancy (41.1%) was for lesions on MRI for new cancer, > = 10 mm with washout. The lowest (1.2%) was for lesions on high-risk screening, <10 mm with persistent kinetics. CONCLUSIONS: A multivariate model shows promise as a decision support tool in predicting malignancy for MRI-detected breast lesions.
Authors: Francesco Sardanelli; Gian M Giuseppetti; Pietro Panizza; Massimo Bazzocchi; Alfonso Fausto; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio Journal: AJR Am J Roentgenol Date: 2004-10 Impact factor: 3.959
Authors: Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw Journal: AJR Am J Roentgenol Date: 2003-09 Impact factor: 3.959
Authors: K Schelfout; M Van Goethem; E Kersschot; C Colpaert; A M Schelfhout; P Leyman; I Verslegers; I Biltjes; J Van Den Haute; J P Gillardin; W Tjalma; J C Van Der Auwera; P Buytaert; A De Schepper Journal: Eur J Surg Oncol Date: 2004-06 Impact factor: 4.424
Authors: Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall Journal: N Engl J Med Date: 2007-03-28 Impact factor: 91.245
Authors: S G Orel; M D Schnall; C M Powell; M G Hochman; L J Solin; B L Fowble; M H Torosian; E F Rosato Journal: Radiology Date: 1995-07 Impact factor: 11.105
Authors: Maria Adele Marino; Paola Clauser; Ramona Woitek; Georg J Wengert; Panagiotis Kapetas; Maria Bernathova; Katja Pinker-Domenig; Thomas H Helbich; Klaus Preidler; Pascal A T Baltzer Journal: Eur Radiol Date: 2015-10-29 Impact factor: 5.315
Authors: Anna G Sorace; Savannah C Partridge; Xia Li; Jack Virostko; Stephanie L Barnes; Daniel S Hippe; Wei Huang; Thomas E Yankeelov Journal: J Med Imaging (Bellingham) Date: 2018-01-22
Authors: K Pinker-Domenig; W Bogner; S Gruber; H Bickel; S Duffy; M Schernthaner; P Dubsky; U Pluschnig; M Rudas; S Trattnig; T H Helbich Journal: Eur Radiol Date: 2011-09-14 Impact factor: 5.315
Authors: Habib Rahbar; Zheng Zhang; Thomas L Chenevert; Justin Romanoff; Averi E Kitsch; Lucy G Hanna; Sara M Harvey; Linda Moy; Wendy B DeMartini; Basak Dogan; Wei T Yang; Lilian C Wang; Bonnie N Joe; Karen Y Oh; Colleen H Neal; Elizabeth S McDonald; Mitchell D Schnall; Constance D Lehman; Christopher E Comstock; Savannah C Partridge Journal: Clin Cancer Res Date: 2019-01-15 Impact factor: 12.531
Authors: Savannah C Partridge; Karen M Stone; Roberta M Strigel; Wendy B DeMartini; Sue Peacock; Constance D Lehman Journal: Acad Radiol Date: 2014-07-04 Impact factor: 3.173
Authors: Jing Luo; Daniel S Hippe; Habib Rahbar; Sana Parsian; Mara H Rendi; Savannah C Partridge Journal: Breast Cancer Res Date: 2019-09-04 Impact factor: 6.466